Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Wearable Suicidal Early Warning System for Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03030924
Recruitment Status : Recruiting
First Posted : January 25, 2017
Last Update Posted : April 20, 2020
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Dr. David Sheridan, Oregon Health and Science University

Brief Summary:
This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.

Condition or disease Intervention/treatment
Suicide Adolescent Behavior Device: Solace

Detailed Description:
This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department with acute suicidality or are admitted to an inpatient psychiatric adolescent unit. The plan is to monitor basic physiologic parameters to assess for trends associated with suicidality noninvasively in an objective manner beyond subjective questionnaires currently available. Upon discharge they will be sent home with a noninvasive monitor to track physiologic parameters.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Physiologic Parameters for Monitoring Adolescent Suicidality
Actual Study Start Date : September 18, 2017
Estimated Primary Completion Date : January 1, 2021
Estimated Study Completion Date : July 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide


Intervention Details:
  • Device: Solace
    Noninvasive physiologic monitor


Primary Outcome Measures :
  1. Heart Rate Variability [ Time Frame: 1 week ]

Secondary Outcome Measures :
  1. Gender [ Time Frame: At enrollment ]
  2. Age [ Time Frame: at enrollment ]
    in Years

  3. Columbia Suicide Severity Score [ Time Frame: 1 week ]
    Numerical based on severity

  4. PHQ-9 Depression Scale [ Time Frame: 1 week ]
    Numerical based on severity

  5. Motion [ Time Frame: 1 week ]
    As detected by an accelerometer in Hz


Other Outcome Measures:
  1. past Medical History [ Time Frame: At enrollment ]
  2. Medications [ Time Frame: At enrollment and daily for one week after discharge ]
    Daily medications



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   13 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Adolescents presenting with acute suicidal thoughts or attempts in the pediatric emergency department (13-19 years of age).
Criteria

Inclusion Criteria:

  • acute suicidality
  • consenting individual present in the emergency department

Exclusion Criteria:

  • medical admission for an ingestion or other reason

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03030924


Contacts
Layout table for location contacts
Contact: David Sheridan, MD 5034941691 sheridda@ohsu.edu
Contact: David C Sheridan, MD 5034941691 sheridda@ohsu.edu

Locations
Layout table for location information
United States, Oregon
OHSU Recruiting
Portland, Oregon, United States, 97239
Contact: David Sheridan, MD    503-494-1691    sheridda@Ohsu.edu   
Sponsors and Collaborators
Oregon Health and Science University
National Institute of Mental Health (NIMH)
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Layout table for investigator information
Principal Investigator: David Sheridan, MD Oregon Health and Science University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Dr. David Sheridan, Assistant Professor of Emergency Medicine/Pediatrics, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT03030924    
Other Study ID Numbers: STUDY00016409
5K12HL133115 ( U.S. NIH Grant/Contract )
First Posted: January 25, 2017    Key Record Dates
Last Update Posted: April 20, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dr. David Sheridan, Oregon Health and Science University:
suicide
Additional relevant MeSH terms:
Layout table for MeSH terms
Suicide
Self-Injurious Behavior
Behavioral Symptoms